MetaVia Inc.

US$1.43As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:MTVAHealthcare
Country USA
PE (Fwd) •••
TSR 7Y CAGR (75.67%)
Div yield —
ROE (175.68%)
Biotechnology
Beta (5Y) 1.24
PE TTM —
TSR TTM (86.90%)
Mkt cap US$9.421M
ROIC (111.62%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.67
17.00%
71.10%
Hold 10|8|12|3|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.02
24.52%
17.18%
10.27%
(3.31%)
Revenue$M
1.227
1.197
1.225
1.279
9.29%
0.68%
0.30%
7.44%
Peers (US$9.421M)
Cap (US$)
PE
9.286M
—
Capital
TTM
5Y
10Y
Leveragex
1.086
0.015
0.013
EBIT/Intx
0.997
0.329
0.333
Own earn%
(13.25)
13.90
13.99
Sh yield%
12.70
27.61
26.14
Owners
Insiders/Inst%
0.18
65.65
Short interest%
2.42
SBC / revenue%
4.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
24–31
$1 testx
0.0
Incr. ROIC%
34